Christopher Causey - 24 Jul 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
24 Jul 2025
Transactions value $
$0
Form type
4
Date filed
28 Jul 2025, 06:13
Previous filing
04 Nov 2024
Next filing
02 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CAUSEY CHRISTOPHER Director C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING /s/ John S. Hess, Jr. under Power of Attorney 2025-07-25 0001237334

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +1.19K +32.38% $0.00 4.87K 25 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Unit Options Exercise $0 -1.19K -100% $0.00 0 25 Jul 2025 Common Stock 1.19K $0.00 Direct F1, F2
transaction UTHR Stock Options Award $0 +3.65K $0.00 3.65K 24 Jul 2025 Common Stock 3.65K $306.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock.
F2 Not applicable as restricted stock units do not have an expiration date.
F3 Annual non-employee director award.